Sort by:
- Doctors (22)
- Locations (18)
ON L6H 0J8, CA
Sheldon Herzig
Contact Info
Office Hours
- Today
- 8:30AM - 5:00PM
Sheldon Herzig
About Sheldon Herzig
Dr. Sheldon Herzig is one of the worlds most respected and experienced refractive eye surgeons. He has pioneered the development and application of leading-edge technologies in advanced refractive surgery. He has also done extensive work on the use of ultrasound and foldable lenses in advanced refractive surgery and the development of outpatient cataract surgery. Dr. Herzig’s work with thousands of patients has led to technique innovations on which he has lectured extensively around the world. He is respected by the medical community worldwide for his publications, scientific papers and formal presentations.
Dr. Herzig completed his ophthalmology residency at the University of Toronto, after which he completed his fellowship at the Mary Shields Eye Hospital in Dallas, Texas, where he was trained in the most advanced micro-surgical techniques for refractive surgery. Dr. Herzig is a member of the surgical staff at North York General Hospital. In 1996, Dr. Herzig co-founded the Herzig Eye Institute with businesswoman Cherry Tabb. A centre of excellence that is recognized worldwide, the Herzig Eye Institute and Dr. Herzig have treated more than 150,000 patients from all over Canada, 42 states and 23 countries worldwide, from Bermuda to Singapore to South Africa and has trained – and treated – several hundred of the world’s leading advanced refractive surgeons.
Dr. Herzig is the past president of the Canadian Society of Cataract and Refractive Surgery (1998-2000) and continues, through his practice and teachings, to be on the cutting edge of his specialty using the most advanced state-of-the-art technology to provide each patient with a custom vision correction to meet their unique needs.
Select Your Region
Latin America
References
1. Patient Survey, STAAR Surgical ICL Data Registry, 2018
2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018
3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.
Important Safety Information
The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.